Page last updated: 2024-08-25

oxazolidin-2-one and telcagepant

oxazolidin-2-one has been researched along with telcagepant in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (37.50)29.6817
2010's5 (62.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Assaid, C; Dodick, DW; Fan, X; Ferrari, MD; Froman, S; Galet, V; Ho, TW; Koppen, H; Kost, J; Leibensperger, H; Lines, C; Winner, PK1
Edvinsson, L1
Edvinsson, L; Hargreaves, RJ; Kane, SA; Lynch, JJ; Regan, CP1
Chan, KY; Danser, AH; de Vries, R; Edvinsson, L; Eftekhari, S; Garrelds, IM; Hargreaves, RJ; Kane, SA; Kimblad, PO; Lynch, J; Maassenvandenbrink, A; van den Bogaerdt, AJ1
Assaid, C; Dodick, DW; Ho, TW; Kost, J; Lines, C1
Dodick, DW; Ferrari, MD; Ho, TW; Kost, J; Lines, C; Olesen, J1
Cui, XP; Lin, H; Lin, M; Mu, JS; Ye, JX1

Reviews

1 review(s) available for oxazolidin-2-one and telcagepant

ArticleYear
Efficacy, safety, and tolerability of telcagepant in the treatment of acute migraine: a meta-analysis.
    Pain practice : the official journal of World Institute of Pain, 2015, Volume: 15, Issue:2

    Topics: Acute Disease; Azepines; Calcitonin Gene-Related Peptide Receptor Antagonists; Humans; Imidazoles; Migraine Disorders; Oxazolidinones; Serotonin 5-HT1 Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines

2015

Trials

3 trial(s) available for oxazolidin-2-one and telcagepant

ArticleYear
Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial.
    Lancet (London, England), 2008, Dec-20, Volume: 372, Issue:9656

    Topics: Adult; Azepines; Calcitonin Gene-Related Peptide; Calcitonin Gene-Related Peptide Receptor Antagonists; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Imidazoles; Male; Migraine Disorders; Oxazolidinones; Serotonin Receptor Agonists; Severity of Illness Index; Tryptamines

2008
Sustained pain freedom and no adverse events as an endpoint in clinical trials of acute migraine treatments: application to patient-level data from a trial of the CGRP receptor antagonist, telcagepant, and zolmitriptan.
    Cephalalgia : an international journal of headache, 2011, Volume: 31, Issue:3

    Topics: Adult; Analgesics; Azepines; Calcitonin Gene-Related Peptide Receptor Antagonists; Double-Blind Method; Female; Humans; Imidazoles; Male; Migraine Disorders; Oxazolidinones; Pain; Research Design; Serotonin 5-HT1 Receptor Antagonists; Tryptamines

2011
Antimigraine efficacy of telcagepant based on patient's historical triptan response.
    Headache, 2011, Volume: 51, Issue:1

    Topics: Adult; Azepines; Calcitonin Gene-Related Peptide Receptor Antagonists; Double-Blind Method; Female; Humans; Imidazoles; Male; Migraine Disorders; Oxazolidinones; Pain; Surveys and Questionnaires; Tryptamines

2011

Other Studies

4 other study(ies) available for oxazolidin-2-one and telcagepant

ArticleYear
CGRP-receptor antagonism in migraine treatment.
    Lancet (London, England), 2008, Dec-20, Volume: 372, Issue:9656

    Topics: Animals; Azepines; Calcitonin Gene-Related Peptide; Calcitonin Gene-Related Peptide Receptor Antagonists; Cerebrovascular Circulation; Humans; Imidazoles; Migraine Disorders; Oxazolidinones; Serotonin Receptor Agonists; Tryptamines

2008
Molecule of the month. Telcagepant.
    Drug news & perspectives, 2009, Volume: 22, Issue:2

    Topics: Azepines; Calcitonin Gene-Related Peptide Receptor Antagonists; Humans; Imidazoles; Migraine Disorders; Oxazolidinones; Randomized Controlled Trials as Topic; Tryptamines

2009
Comparison of the vasoconstrictor effects of the calcitonin gene-related peptide receptor antagonist telcagepant (MK-0974) and zolmitriptan in human isolated coronary arteries.
    Journal of cardiovascular pharmacology, 2010, Volume: 55, Issue:5

    Topics: Adult; Azepines; Calcitonin Gene-Related Peptide Receptor Antagonists; Coronary Vessels; Dose-Response Relationship, Drug; Humans; Imidazoles; In Vitro Techniques; Middle Aged; Migraine Disorders; Oxazolidinones; Tryptamines; Vasoconstriction; Vasodilation; Vasodilator Agents

2010
Characterization of the calcitonin gene-related peptide receptor antagonist telcagepant (MK-0974) in human isolated coronary arteries.
    The Journal of pharmacology and experimental therapeutics, 2010, Sep-01, Volume: 334, Issue:3

    Topics: Adult; Aged; Azepines; Calcitonin Gene-Related Peptide Receptor Antagonists; Coronary Vessels; Cyclic AMP; Female; Humans; Imidazoles; Immunohistochemistry; In Vitro Techniques; Male; Middle Aged; Muscle, Smooth, Vascular; Oxazolidinones; Serotonin Receptor Agonists; Tryptamines; Young Adult

2010